{"schema_version":"secwatch.filing_event.v1","accession":"0001178913-26-002900","form_type":"8-K","ticker":"SLXN","cik":"0002022416","company_name":"Silexion Therapeutics Corp","filed_at":"2026-05-26T12:48:49+00:00","discovered_at":"2026-05-26T12:50:00.888047+00:00","generated_at":"2026-05-26T12:50:27.315562+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"confidence":"high","headline":"Silexion Therapeutics announces 1-for-10 reverse share split to maintain Nasdaq listing","bullets":["Reverse share split at 1:10 ratio; effective after market close May 28, 2026; split-adjusted trading begins May 29, 2026.","Ticker remains SLXN; new CUSIP assigned; par value increases from $0.0135 to $0.135 per share.","No fractional shares issued; DTC participants' fractional shares rounded up to nearest whole share.","Split intended to maintain Nasdaq minimum bid price compliance (Rule 5550(a)(2)) and support equity financings."],"urls":{"canonical":"https://secwatch.observer/filing/0001178913-26-002900","json":"https://secwatch.observer/filing/0001178913-26-002900.json","markdown":"https://secwatch.observer/filing/0001178913-26-002900.md","text":"https://secwatch.observer/filing/0001178913-26-002900.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/2022416/000117891326002900/0001178913-26-002900-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2022416/000117891326002900/zk2635400.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-26T12:50:27.315562+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}